Q4 2024 Arrowhead Pharmaceuticals Inc Earnings Call Transcript
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals conference call throughout today's recorded presentation. (Operator Instructions) and I had a conference over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead Vince.
Thank you. Good afternoon. Thank you for joining us today to discuss Arrowhead's results for its fiscal 2024 year ended, September 30th 2024 with us today from management are President and CEO Doctor Chris Anzalone who will provide an overview of the quarter. Doctor Bruce Gi, Interim Chief, medical scientists, who will provide an update on our cardio metabolic pipeline. Andy, senior Vice President and head of global cardiometabolic franchise who will provide an update on commercialization activities. Dr James Hamilton, chief of discovery and translational medicine, who will discuss our earlier stage development programs. And Ken Moskowsky, Chief Financial Officer who will give a review of the financials, we will then open the call to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |